arrow
P

Pamela Österlund

Finnish Institute for Health and Welfare
H指数:28
被引数:5,130

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “Long-term neutralization capacity of vaccine and breakthrough infection induced SARS-CoV-2 specific antibodies against omicron subvariants BA.2, XBB.1.5, and JN.1” [Vaccine 68 (2025) 127894]

勘误:关于“疫苗和突破性感染诱导的SARS-CoV-2特异性抗体对奥密克戎亚变种BA.2、XBB.1.5和JN.1的长期中和能力” [Vaccine 68 (2025) 127894]

Vaccine
IF3.5
2025-11-070
OAAI
Long-term neutralization capacity of vaccine and breakthrough infection induced SARS-CoV-2 specific antibodies against omicron subvariants BA.2, XBB.1.5, and JN.1

疫苗和突破性感染诱导的SARS-CoV-2特异性抗体对奥密克戎亚谱系BA.2、XBB.1.5和JN.1的长期中和能力

Vaccine
IF3.5
2025-10-280
OAAI
Highly Pathogenic Avian Influenza (HPAI) H5N1 virus in Finland in 2021-2023-Genetic diversity of the viruses and infection kinetics in human dendritic cells

2021芬兰的高致病性禽流感 (HPAI) H5N1病毒-2023病毒的遗传多样性和人类树突状细胞的感染动力学

2025-01-100
OAAI
The comprehensive SARS-CoV-2 'hijackome' knowledge base
2024-12-090
OAAI
Neutralizing antibodies after the third COVID-19 vaccination in healthcare workers with or without breakthrough infection
2024-02-234
OA
Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants
2023-03-248
OAAI
Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose

第三次新型冠状病毒肺炎mRNA疫苗剂量后针对Omicron变体的持续T细胞介导的免疫反应

2023-01-2313
OAAI
Strong Neutralizing Antibody Responses to SARS-CoV-2 Variants Following a Single Vaccine Dose in Subjects With Previous SARS-CoV-2 Infection

在先前患有SARS-CoV-2感染的受试者中,单次疫苗剂量后对SARS-CoV-2变体的强烈中和抗体反应

2022-11-197
OAAI
Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants
2022-05-0550
OAAI
COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants
2021-06-28213
OAAI